TrialSite News has reported extensively about XBiotech’s quest to cure Hidradenitis suppurative. Our readers struggling with Hidradenitis suppurativa will be happy to know that Alice Gottlieb, MD, Ph.D., will chair the company’s upcoming Phase II bermekimab clinical...
Gottlieb, Alice MD Content
Category
Dr. Alice Gottlieb Presents HS Bermekimab Findings at AADAM
XBiotech reports that Scientific Board member Dr. Alice Gottlieb will present “Bermekimab Shows Efficacy for Treating Hidradenitis Suppurative HS, Including Marked Reduction in Pain” during the afternoon session on March 2nd, 2019 at the American Academy of...